Clinical Trials List
2026-02-28 - 2031-02-21
Phase III
Recruiting6
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張哲慈 Division of Rheumatology
- 陳彥輔 Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鄭喬峯 風濕免疫科
- 呂政勳 風濕免疫科
- CHIEH-YU SHEN 風濕免疫科
- SONG-CHOU HSIEH 風濕免疫科
- 郭佑民 風濕免疫科
- 劉津秀 風濕免疫科
- KO-JEN LI 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡弘正 風濕免疫科
- 曹彥博 風濕免疫科
- Wei-Sheng Chen 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
600 participants
